{
  "compound": "THC (Namisol oral tablet)",
  "condition": "ALZHEIMERS",
  "effect_size": "Non-significant (dose-finding needed)",
  "study_type": "RCT",
  "source": "NORML:ALZHEIMERS_RCT_003",
  "participants": "50 patients with dementia",
  "year": 2015,
  "notes": "THC for Dementia-Related Neuropsychiatric Symptoms: Phase 2 Trial",
  "confidence": "medium",
  "abstract": "No significant difference from placebo on primary endpoint; Trends for agitation improvement; Dose may have been too low"
}